ALRN - Aileron Therapeutics GAAP EPS of -$0.86 beats by $0.16
2024-05-15 17:47:41 ET
More on Aileron Therapeutics
- Aileron announces pricing of underwritten registered direct offering priced at-the-market under Nasdaq rules of up to about $40M
- Aileron Therapeutics announces positive data from its early stage pulmonary fibrosis treatment trial
- Seeking Alpha’s Quant Rating on Aileron Therapeutics
- Historical earnings data for Aileron Therapeutics
- Financial information for Aileron Therapeutics